We are 6 days away from the AHA conference and RVX opportunity to show the world this virtually unknown company with a novel epigenetic science approach that may one day cure many many diseases just like Humana , If RVX doesn't get major world wide media and news attention i will be shocked, Any good data data data on all endpoints released on Saturday should light a fire under the SP, Below is some of the details awarded to those very companies chosen at the AHA late breaking sessions
The buzz has already started, here’s why you should submit your research:
Top-Ranked Publication:
Accepted abstracts are published in the most prestigious cardiovascular journal, the American Heart Association’s Circulation (opens in new window), reaching over 26,000 subscribers and receiving over 1.4 million monthly page views.
Increase Your Global Reach:
Reach a global audience by presenting your science at the AHA’s Scientific Sessions, one of the most influential and impactful cardiovascular conference in the world. In 2018, Scientific Sessions received:
- 23,046+ stories developed by national, local, and international media
- 18.8 billion media impressions worldwide
- Over 300 million impressions across social media
- Thousands of attendees from over 100 countries
